Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

A recent study by UC San Francisco has uncovered that menopause has a negative influence on several prodromal symptoms of Multiple Sclerosis, thus catalysing its progression. Multiple Sclerosis ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

This helps reduce inflammation and MS symptoms. Treatment may include: Healthcare professionals typically give high dose steroids through an IV once daily for 3 to 5 days. This usually occurs in ...

Background Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because ...

SYMPTOMS such as skin sensation disturbances, visual disturbances, and obesity may precede a diagnosis of paediatric multiple sclerosis (MS) by up to five years, recent research has shown. A ...

When an individual experiences fecal impaction, they usually need treatment to pass the stool ... You will likely have other symptoms in addition to constipation. The symptoms typically get worse the ...